What does the presence of atypical lymphocytes, burr (echinocyte) cells, and ovalocytes on a peripheral blood smear suggest, and what initial work‑up should be done?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Peripheral Blood Smear Findings: Atypical Lymphocytes, Burr Cells, and Ovalocytes

The combination of atypical lymphocytes, burr cells (echinocytes), and ovalocytes on a peripheral blood smear suggests a mixed picture requiring systematic evaluation for viral infection (particularly EBV/CMV), renal dysfunction, and hereditary red cell disorders or myelofibrosis, respectively.

Understanding Each Cell Type

Atypical Lymphocytes

Atypical lymphocytes represent activated, enlarged lymphocytes with increased DNA synthesis that indicate a polyclonal immune response to antigenic stimulation 1. These cells appear in:

  • Viral infections (infectious mononucleosis, CMV, EBV, COVID-19)
  • Drug reactions
  • Autoimmune disorders
  • Post-transplant immune reactions
  • Malignancies (though less common)

Critical distinction: While atypical lymphocytes can appear in both benign reactive conditions and malignancies like Sézary syndrome or adult T-cell leukemia/lymphoma, the presence of >5% atypical lymphocytes with specific immunophenotyping is required for malignant diagnoses 2. Recent evidence shows COVID-19 patients demonstrate atypical lymphocytes in 52.5% of cases 3.

Burr Cells (Echinocytes)

These spiculated red cells with evenly distributed projections primarily indicate:

  • Renal failure (uremia)
  • Liver disease
  • Pyruvate kinase deficiency
  • Artifact from blood storage

Ovalocytes (Elliptocytes)

Elongated red cells suggest 4:

  • Hereditary elliptocytosis (when predominant)
  • Myelofibrosis or myeloproliferative disorders
  • Iron deficiency anemia
  • Megaloblastic anemia
  • Thalassemia

Initial Workup Algorithm

Step 1: Complete Blood Count with Differential

  • Absolute lymphocyte count
  • Platelet count
  • Hemoglobin/hematocrit
  • White blood cell count with manual differential

Step 2: Targeted Laboratory Testing

For atypical lymphocytes:

  • EBV serology (VCA-IgM, VCA-IgG, EBNA)
  • CMV serology (IgM, IgG)
  • HIV testing
  • COVID-19 testing if clinically indicated
  • Flow cytometry if lymphocyte count >5 × 10⁹/L to rule out lymphoproliferative disorders 5

For burr cells:

  • Renal function panel (BUN, creatinine)
  • Liver function tests (AST, ALT, bilirubin)
  • Electrolytes

For ovalocytes:

  • Reticulocyte count
  • Iron studies (ferritin, TIBC, serum iron)
  • LDH (elevated in hemolysis or myeloproliferative disorders)
  • Peripheral blood smear review for teardrop cells (suggesting myelofibrosis)

Step 3: Advanced Testing Based on Initial Results

If lymphocytosis with atypical cells:

  • Flow cytometry panel: CD3, CD4, CD7, CD8, CD25 for T-cell disorders 2
  • For B-cell evaluation: CD5, CD19, CD20, CD23 5
  • Consider bone marrow biopsy if flow cytometry suggests malignancy

If ovalocytes predominate (>25% of RBCs):

  • Osmotic fragility testing for hereditary elliptocytosis
  • Bone marrow biopsy if myelofibrosis suspected (presence of teardrop cells, elevated LDH, splenomegaly)

Common Pitfalls to Avoid

  1. Misidentifying malignant cells: Large atypical lymphocytes at the feathered edge of smears can represent CMV-infected endothelial cells in immunocompromised patients, not malignancy 6. These cells are 50-60 microns with granular eosinophilic cytoplasmic inclusions.

  2. Assuming all atypical lymphocytes indicate malignancy: The vast majority represent benign reactive processes 1. Malignancy requires sustained lymphocytosis >5 × 10⁹/L with specific immunophenotyping 5.

  3. Ignoring clinical context: A patient with acute viral symptoms and atypical lymphocytes requires different workup than an asymptomatic patient with chronic lymphocytosis.

  4. Overlooking artifact: Burr cells can result from prolonged blood storage or improper smear preparation 7.

Risk Stratification for Urgent Evaluation

Immediate hematology consultation if:

  • Absolute lymphocyte count >5 × 10⁹/L sustained over weeks
  • Presence of blasts or immature cells
  • Severe anemia (Hgb <8 g/dL) with ovalocytes and teardrop cells
  • Thrombocytopenia with atypical lymphocytes (consider TTP, HLH, or malignancy)
  • Immunocompromised patient with large atypical cells (rule out CMV viremia) 6

Routine follow-up appropriate if:

  • Mild atypical lymphocytosis with viral symptoms
  • Isolated burr cells with known renal disease
  • Mild ovalocytosis (<10%) without anemia

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.